Amwise focuses on advanced precision medicine in oncology, striving to shape a better world for cancer patients. We provide healthcare professionals and patients with quantitative data to help determine the appropriate approaches in treatment. We expect patients to receive the highest healing possibility with minimal side effects by avoiding unnecessary treatments.
 

Amwise successfully developed advanced precision diagnostics based on Asian genes. Current technology can help breast cancer patients evaluate the necessity of chemotherapy and radiation therapy. Amwise is also developing prognosis testing for colorectal cancer. Amwise is also developing a chemo predictor to apply in Pancreatic Cancer and utilizing and integrating the most cutting-edge technology to lead the sector into a new era.